Efficacy and Safety of Polyethylene Glycol Compared With Sodium Picosulphate for Bowel Preparation Before Colonoscopy
NCT ID: NCT01093274
Last Updated: 2010-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of PICOPREP and PEG-ELS for Bowel Preparation for Colonoscopy
NCT01356407
Comparison of Bowel Cleansing Regimens Prior to Colonoscopy
NCT01649674
Low-volume Polyethylene Glycol Bowel Preparation for Colonoscopy
NCT01929590
Polyethylene Glycol Versus Sodium Phosphate for Colon Preparation After Failure of First Preparation for Colonoscopy
NCT00558376
Safety, Efficacy, and Tolerance of Pico-Salax for Colon Cleansing Prior to Colonoscopy in an Elderly Population
NCT00906217
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Polyethylene glycol
Preparation with Polyethylene Glycol and bisacodyl
Polyethylene Glycol
3 Liters solution
Picolax
Preparation with Sodium Picosulphate and Bisacodyl.
Sodium Picosulphate
2 Sachets
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sodium Picosulphate
2 Sachets
Polyethylene Glycol
3 Liters solution
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-80
Exclusion Criteria
* Symptomatic congestive heart failure
* Recent myocardial infarction
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rabin Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rabin Medical Center- Beilinson hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eyal Gal, MD
Role: PRINCIPAL_INVESTIGATOR
Rabin Medical Center - Beilinson hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rabin Medical Center - Beilinson Hospital
Petah Tikva, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Gal001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.